Hookipa Pharma Priced, Nasdaq: HOOK

Phase 2 biotech developing T cell immunotherapies for cancer/infectious diseases.

Industry: Health Care

Latest Trade: $13.88 -0.13 (-0.9%)

First Day Return: 0.0%

Return from IPO: 0.0%

Industry: Health Care

We are a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on our proprietary arenavirus platform that is designed to reprogram the body's immune system. We are using our "off-the-shelf" technologies, VaxWave and TheraT, to elicit directly within patients a powerful and durable response of antigen-specific killer T cells and antibodies, thereby activating essential immune defenses against infectious diseases and cancers. We believe that our technologies can meaningfully leverage this immune defense mechanism for prophylactic and therapeutic purposes by eliciting killer T cell response levels previously not achieved by other published immunotherapy approaches. Our lead infectious disease product candidate, HB-101, is in a Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from living cytomegalovirus-positive donors. Our lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. We plan to file an investigational new drug application, or IND, with the U.S. Food and Drug Administration, or the FDA, for HB-201 and HB-202 in the first half and second half of 2019, respectively. We have also entered into a strategic partnership with Gilead Sciences to accelerate building a pipeline of additional infectious disease product candidates in a cost efficient manner.
more less
IPO News for Hookipa Pharma
more
IPO Data
IPO File Date 03/22/2019
Offer Price $14.00
Price Range $14.00 - $16.00
Offer Shares (mm) 6.0
Deal Size ($mm) $84
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 04/17/2019
Offer Price $14.00
Price Range $14.00 - $16.00
Offer Shares (mm) 6.0
Deal Size ($mm) $84
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters New York, NY
Founded 2011
Employees 78
Website www.hookipapharma.com